Drugs Made In America Acquisition II Corp. Unit

public_traded

Drugs Made In America Acquisition II Corp. Unit is publicly traded on NASDAQ under ticker DMIIU.

A SPAC (blank check company) incorporated in the Cayman Islands to pursue a business combination. The company aims to focus on pharmaceutical / drug sector targets to reduce U.S. reliance on global drug manufacturing. Each unit consists of one ordinary share and one right to receive one-tenth of a share upon completion of a qualifying business combination.

View full analysis on MarketSnap